The Phelan-McDermid Syndrome Foundation is sharing an important update with our community: Neuren’s Phase 3 clinical trial of NNZ-2951, known as the “Koala” study, is now active and listed on clinicaltrials.gov.
A new FAQ from Jaguar Gene Therapy is now available, including updated details about the JAG201 clinical study. This FAQ addresses…
Neuren has released a statement that the drug was found to be generally safe at the dose tested, having no serious adverse effects.
Neuren has released a statement that the drug was found to be generally safe at the dose tested, having no serious adverse effects.
Use this chart to help you make an informed decision when considering participation in a clinical trial.
